BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 908750)

  • 1. The properties of immune complexes formed by human antibodies to factor VIII.
    Lazarchick J; Hoyer LW
    J Clin Invest; 1977 Nov; 60(5):1070-9. PubMed ID: 908750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rabbit antibodies against the procoagulant activity (VIII:C) of human factor VIII. Some theoretical and practical considerations on the human factor VIII molecule using heterologous antibodies.
    Tran TH; Marbet GA; Duckert F
    Thromb Haemost; 1981 Dec; 46(4):699-705. PubMed ID: 6800051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on human antihemophilic factor. Evidence for a covalently linked subunit structure.
    Switzer ME; McKee PA
    J Clin Invest; 1976 Apr; 57(4):925-37. PubMed ID: 1084890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of thrombin treatment of preparations of factor VIII and the Ca2+-dissociated small active fragment.
    Cooper HA; Reisner FF; Hall M; Wagner RH
    J Clin Invest; 1975 Sep; 56(3):751-60. PubMed ID: 1080490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating immune complexes containing anti-VIII antibodies in multi-transfused patients with haemophilia A.
    Kazatchkine MD; Sultan Y; Burton-Kee EJ; Mowbray JF
    Clin Exp Immunol; 1980 Feb; 39(2):315-20. PubMed ID: 6771074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on human factor VIII and its antibodies using radiolabelling and affinity chromatography.
    Kavanagh ML; Wood CN; Davidson JF
    Thromb Haemost; 1981 Jun; 45(3):267-71. PubMed ID: 6792739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunochemical characterization of factor VIII inhibitors.
    Hoyer LW; Gawryl MS; de la Fuente B
    Prog Clin Biol Res; 1984; 150():73-85. PubMed ID: 6431443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content.
    Weiss HJ; Hoyer LW; Rickles FR; Varma A; Rogers J
    J Clin Invest; 1973 Nov; 52(11):2708-16. PubMed ID: 4542944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acquired haemophilia: functional study of antibodies to Factor VIII.
    Allain JP; Gaillandre A; Frommel D
    Thromb Haemost; 1981 Jun; 45(3):285-9. PubMed ID: 6792741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural antibodies to factor VIII.
    Lacroix-Desmazes S; Moreau A; Pashov A; Sooryanarayana ; Stahl D; Saint-Remy JM; Kaveri SV; Kazatchkine MD
    Semin Thromb Hemost; 2000; 26(2):157-65. PubMed ID: 10919408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dissociation of factor VIII procoagulant antigen VIII:CAg and factor VIII related antigen VIIIR:Ag by EDTA - influence of divalent cation on the binding of VIII:CAg and VIIIR:Ag.
    Tran TH; Duckert F
    Thromb Haemost; 1983 Aug; 50(2):547-51. PubMed ID: 6415848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of factor VIII antigen in hemophilic plasmas with human antibodies to factor VIII.
    Zimmerman TS; de la Pointe L; Edgington TS
    J Clin Invest; 1977 May; 59(5):984-9. PubMed ID: 853128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunochemical characterization of antibodies to factor VIII in hemophilic and nonhemophilic patients.
    Allain JP; Gaillandre A; Lee H
    J Lab Clin Med; 1981 Jun; 97(6):791-800. PubMed ID: 6785371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered serum factor VIII-related antigen (VIII : AGN)/von Willebrand factor (VIII : vWf) in haemophiliacs with inhibitors to factor VIII procoagulant activity (VIII : C).
    Ballard JO; Sanders JC; Eyster ME
    Thromb Haemost; 1981 Feb; 45(1):68-72. PubMed ID: 6166064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti idiotypic recognition of auto and allo antibodies to factor VIII by immunoglobulin preparations from single blood donors and large plasma pool.
    Sultan Y; Rossi F; Kazatchkine M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(4):539-43. PubMed ID: 1714857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of immune-complex size and antigen-antibody ratio on immune complex detection with monoclonal rheumatoid factor and C1q.
    Vanham G; Bloemmen FJ; Ceuppens JL; Stevens EA
    J Clin Lab Immunol; 1984 Oct; 15(2):63-8. PubMed ID: 6335179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of factor VIII inactivation by human antibodies. IV. Antibody binding prevents factor VIII proteolysis by thrombin.
    Lazarchick J; Ashby MA; Lazarchick JJ; Sens DA
    Ann Clin Lab Sci; 1986; 16(6):497-501. PubMed ID: 3099625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation of human antibodies to factor VIII.
    Lavergne JM; Meyer D; Koutts J; Larrieu MJ
    Br J Haematol; 1978 Dec; 40(4):631-41. PubMed ID: 365219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defective ristocetin-induced platelet aggregation in von Willebrand's disease and its correction by factor VIII.
    Weiss HJ; Rogers J; Brand H
    J Clin Invest; 1973 Nov; 52(11):2697-707. PubMed ID: 4201262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physiopathology of catalytic antibodies: the case for factor VIII-hydrolyzing immunoglobulin G.
    Wootla B; Dasgupta S; Mallet V; Kazatchkine MD; Nagaraja V; Friboulet A; Kaveri SV; Lacroix-Desmazes S
    Blood Coagul Fibrinolysis; 2006 Jun; 17(4):229-34. PubMed ID: 16651863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.